Cholesterol
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
Common Name | Cholesterol(F05336) |
2D Structure | |
Description | Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The name originates from the Greek chole- (bile) and stereos (solid), and the chemical suffix -ol for an alcohol, as researchers first identified cholesterol in solid form in gallstones in 1784. In the body, cholesterol can exist in either the free form or as an ester with a single fatty acid (of 10-20 carbons in length) covalently attached to the hydroxyl group at position 3 of the cholesterol ring. Because of the mechanism of synthesis plasma cholesterol esters tend to contain relatively high proportions of polyunsaturated fatty acids. Most of the cholesterol consumed as a dietary lipid exists as cholesterol esters. Cholesterol esters have a lower solubility in water than cholesterol and are more hydrophobic. They are hydrolyzed by pancreatic enzymes, cholesterol esterase, to produce cholesterol and free fatty acids. |
FRCD ID | F05336 |
CAS Number | 57-88-5 |
PubChem CID | 11025495 |
Formula | C27H46O |
IUPAC Name | (8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
InChI Key | HVYWMOMLDIMFJA-FNOPAARDSA-N |
InChI | InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21?,22+,23-,24+,25+,26+,27-/m1/s1 |
Canonical SMILES | CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
Isomeric SMILES | C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CCC(C4)O)C)C |
Wikipedia | Cholesterol |
Synonyms | (8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol Cholest-5-en-3-ol CHEMBL1867358 CTK6A7338 MolPort-009-199-159 AKOS015841761 DS-3392 NCGC00159351-04 AK105936 |
Classifies | Animal Toxin |
Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
Kingdom | Organic compounds |
Superclass | Lipids and lipid-like molecules |
Class | Steroids and steroid derivatives |
Subclass | Cholestane steroids |
Intermediate Tree Nodes | Not available |
Direct Parent | Cholesterols and derivatives |
Alternative Parents | |
Molecular Framework | Aliphatic homopolycyclic compounds |
Substituents | Cholesterol-skeleton - Cholesterol - Hydroxysteroid - 3-hydroxysteroid - 3-hydroxy-delta-5-steroid - Delta-5-steroid - Cyclic alcohol - Secondary alcohol - Organic oxygen compound - Hydrocarbon derivative - Organooxygen compound - Alcohol - Aliphatic homopolycyclic compound |
Description | This compound belongs to the class of organic compounds known as cholesterols and derivatives. These are compounds containing a 3-hydroxylated cholestane core. |
Properties
Property Name | Property Value |
---|---|
Molecular Weight | 386.664 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 5 |
Complexity | 591 |
Monoisotopic Mass | 386.355 |
Exact Mass | 386.355 |
XLogP | 8.7 |
Formal Charge | 0 |
Heavy Atom Count | 28 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
ADMET
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9749 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.8184 |
P-glycoprotein Substrate | Substrate | 0.6477 |
P-glycoprotein Inhibitor | Inhibitor | 0.6404 |
Non-inhibitor | 0.5290 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.7691 |
Distribution | ||
Subcellular localization | Mitochondria | 0.4852 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8257 |
CYP450 2D6 Substrate | Non-substrate | 0.8794 |
CYP450 3A4 Substrate | Substrate | 0.7439 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9355 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9194 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9519 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9177 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8638 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6721 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7730 |
Non-inhibitor | 0.7552 | |
AMES Toxicity | Non AMES toxic | 0.8888 |
Carcinogens | Non-carcinogens | 0.9320 |
Fish Toxicity | High FHMT | 0.9956 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9953 |
Honey Bee Toxicity | High HBT | 0.8718 |
Biodegradation | Not ready biodegradable | 0.9825 |
Acute Oral Toxicity | I | 0.5508 |
Carcinogenicity (Three-class) | Non-required | 0.5893 |
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -4.8096 | LogS |
Caco-2 Permeability | 1.4990 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.8078 | LD50, mol/kg |
Fish Toxicity | -0.2120 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 1.2573 | pIGC50, ug/L |
References
Title | Journal | Date | Pubmed ID |
---|---|---|---|
Methyl-β-cyclodextrin potentiates the BITC-induced anti-cancer effect through modulation of the Akt phosphorylation in human colorectal cancer cells. | Biosci Biotechnol Biochem | 2018 Sep 10 | 30200817 |
Dietary supplementation of Yucca schidigera extract enhances productive and reproductive performances, blood profile, immune function, and antioxidant status in laying Japanese quails exposed to lead in the diet. | Poult Sci | 2018 Sep 1 | 29846703 |
Fumonisin B<sub>1</sub> exposure increases Hsp70 expression in the lung and kidney of rats without inducing significant oxidative stress. | Acta Vet Hung | 2018 Sep | 30264617 |
Toxicological analysis of roast duck flavor components. | Food Chem Toxicol | 2018 Sep | 29208505 |
Safety assessment of Morus nigra L. leaves: Acute and subacute oral toxicity studies in Wistar rats. | J Ethnopharmacol | 2018 Oct 5 | 29772355 |
Peroxisome proliferator-activated receptor α attenuates high-cholesterol diet-induced toxicity and pro-thrombotic effects in mice. | Arch Toxicol | 2018 Oct 19 | 30341732 |
Therapeutic use of curcumin-encapsulated and curcumin-primed exosomes. | J Cell Physiol | 2018 Oct 14 | 30317632 |
A transcriptomic analysis of black cohosh: Actein alters cholesterol biosynthesis pathways and synergizes with simvastatin. | Food Chem Toxicol | 2018 Oct | 29969672 |
The effect of electronic-cigarettes aerosol on rat brain lipid profile. | Biochimie | 2018 Oct | 30077815 |
Fipronil (Phenylpyrazole) induces hemato-biochemical, histological and genetic damage at low doses in common carp, Cyprinus carpio (Linnaeus, 1758). | Ecotoxicology | 2018 Nov | 30242594 |
Influence of Chronic Toxicity, Lipid Metabolism, Learning and Memory Ability, and Related Enzyme in Sprague-Dawley Rats by Long-Term Chromium Malate Supplementation. | Biol Trace Elem Res | 2018 May 24 | 29797207 |
Modulation of key lipid raft constituents in primary rat hepatocytes by fumonisin B<sub>1</sub> - Implications for cancer promotion in the liver. | Food Chem Toxicol | 2018 May | 29510220 |
Does Low-Protein Diet Influence the Uremic Toxin Serum Levels From the Gut Microbiota in Nondialysis Chronic Kidney Disease Patients? | J Ren Nutr | 2018 May | 29439931 |
Strain-Specific Quantification of Native Probiotic Bacillus spp. and Their Effect on Liver Function and Gut Microflora of Experimental Rats. | Probiotics Antimicrob Proteins | 2018 Mar 6 | 29512027 |
The Effect of Tomatine on Gene Expression and Cell Monolayer Integrity in Caco-2. | Molecules | 2018 Mar 13 | 29533987 |
Dose-Dependent Effects of Multispecies Probiotic Supplementation on the Lipopolysaccharide (LPS) Level and Cardiometabolic Profile in Obese Postmenopausal Women: A 12-Week Randomized Clinical Trial. | Nutrients | 2018 Jun 15 | 29914095 |
Akkermansia muciniphila can reduce the damage of gluco/lipotoxicity, oxidative stress and inflammation, and normalize intestine microbiota in streptozotocin-induced diabetic rats. | Pathog Dis | 2018 Jun 1 | 29668928 |
Mechanism of bisphenol AF-induced progesterone inhibition in human chorionic gonadotrophin-stimulated mouse Leydig tumor cell line (mLTC-1) cells. | Environ Toxicol | 2018 Jun | 29575470 |
An overview of Jatropha curcas meal-induced productive and reproductive toxicity in Japanese quail: Potential mechanisms and heat detoxification. | Theriogenology | 2018 Jun | 29554603 |
Antihyperlipidemic efficacy of aqueous extract of Stevia rebaudiana Bertoni in albino rats. | Lipids Health Dis | 2018 Jul 27 | 30053819 |
Targets
- Specific Function:
- Hormone that seems to suppress insulin ability to stimulate glucose uptake into adipose cells. Potentially links obesity to diabetes.
- Gene Name:
- RETN
- Uniprot ID:
- Q9HD89
- Molecular Weight:
- 11419.195 Da
- General Function:
- Transcriptional repressor activity, rna polymerase ii core promoter proximal region sequence-specific binding
- Specific Function:
- Transcriptional activator required for lipid homeostasis. Regulates transcription of the LDL receptor gene as well as the cholesterol and to a lesser degree the fatty acid synthesis pathway (By similarity). Binds the sterol regulatory element 1 (SRE-1) (5'-ATCACCCCAC-3') found in the flanking region of the LDRL and HMG-CoA synthase genes.
- Gene Name:
- SREBF2
- Uniprot ID:
- Q12772
- Molecular Weight:
- 123686.44 Da
- General Function:
- Sterol 14-demethylase activity
- Specific Function:
- Catalyzes C14-demethylation of lanosterol; it transforms lanosterol into 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol.
- Gene Name:
- CYP51A1
- Uniprot ID:
- Q16850
- Molecular Weight:
- 56805.26 Da
References
- Ekins S, Mankowski DC, Hoover DJ, Lawton MP, Treadway JL, Harwood HJ Jr: Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors. Drug Metab Dispos. 2007 Mar;35(3):493-500. Epub 2006 Dec 28. [17194716 ]
- General Function:
- Xenobiotic-transporting atpase activity
- Specific Function:
- Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.
- Gene Name:
- ABCB1
- Uniprot ID:
- P08183
- Molecular Weight:
- 141477.255 Da
References
- Wang E, Casciano CN, Clement RP, Johnson WW: Cholesterol interaction with the daunorubicin binding site of P-glycoprotein. Biochem Biophys Res Commun. 2000 Oct 5;276(3):909-16. [11027568 ]
- General Function:
- Zinc ion binding
- Specific Function:
- Nuclear receptor. Interaction with RXR shifts RXR from its role as a silent DNA-binding partner to an active ligand-binding subunit in mediating retinoid responses through target genes defined by LXRES. LXRES are DR4-type response elements characterized by direct repeats of two similar hexanuclotide half-sites spaced by four nucleotides. Plays an important role in the regulation of cholesterol homeostasis, regulating cholesterol uptake through MYLIP-dependent ubiquitination of LDLR, VLDLR and LRP8. Interplays functionally with RORA for the regulation of genes involved in liver metabolism (By similarity). Exhibits a ligand-dependent transcriptional activation activity (PubMed:25661920).
- Gene Name:
- NR1H3
- Uniprot ID:
- Q13133
- Molecular Weight:
- 50395.34 Da
References
- Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z: PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J Am Soc Nephrol. 2003 Mar;14(3):593-600. [12595494 ]
- General Function:
- Phospholipid binding
- Specific Function:
- Apolipoprotein B is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor.
- Gene Name:
- APOB
- Uniprot ID:
- P04114
- Molecular Weight:
- 515600.06 Da
- Uniprot ID:
- P02654; P02655; P02656; P55056
- General Function:
- Very-low-density lipoprotein particle receptor binding
- Specific Function:
- Mediates the binding, internalization, and catabolism of lipoprotein particles. It can serve as a ligand for the LDL (apo B/E) receptor and for the specific apo-E receptor (chylomicron remnant) of hepatic tissues.
- Gene Name:
- APOE
- Uniprot ID:
- P02649
- Molecular Weight:
- 36153.83 Da
- General Function:
- Virus receptor activity
- Specific Function:
- Binds LDL, the major cholesterol-carrying lipoprotein of plasma, and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits.(Microbial infection) Acts as a receptor for hepatitis C virus in hepatocytes, but not through a direct interaction with viral proteins (PubMed:10535997, PubMed:12615904). Acts as a receptor for vesicular stomatitis virus (PubMed:23589850). In case of HIV-1 infection, may function as a receptor for extracellular Tat in neurons, mediating its internalization in uninfected cells (PubMed:11100124).
- Gene Name:
- LDLR
- Uniprot ID:
- P01130
- Molecular Weight:
- 95375.105 Da
- General Function:
- Transcriptional activator activity, rna polymerase ii core promoter proximal region sequence-specific binding
- Specific Function:
- Transcriptional activator required for lipid homeostasis. Regulates transcription of the LDL receptor gene as well as the fatty acid and to a lesser degree the cholesterol synthesis pathway (By similarity). Binds to the sterol regulatory element 1 (SRE-1) (5'-ATCACCCCAC-3'). Has dual sequence specificity binding to both an E-box motif (5'-ATCACGTGA-3') and to SRE-1 (5'-ATCACCCCAC-3').
- Gene Name:
- SREBF1
- Uniprot ID:
- P36956
- Molecular Weight:
- 121673.6 Da
- General Function:
- Zinc ion binding
- Specific Function:
- Nuclear receptor that binds DNA as a monomer to ROR response elements (RORE) containing a single core motif half-site 5'-AGGTCA-3' preceded by a short A-T-rich sequence. Key regulator of embryonic development, cellular differentiation, immunity, circadian rhythm as well as lipid, steroid, xenobiotics and glucose metabolism. Considered to have intrinsic transcriptional activity, have some natural ligands like oxysterols that act as agonists (25-hydroxycholesterol) or inverse agonists (7-oxygenated sterols), enhancing or repressing the transcriptional activity, respectively. Recruits distinct combinations of cofactors to target genes regulatory regions to modulate their transcriptional expression, depending on the tissue, time and promoter contexts. Regulates genes involved in photoreceptor development including OPN1SW, OPN1SM and ARR3 and skeletal muscle development with MYOD1. Required for proper cerebellum development, regulates SHH gene expression, among others, to induce granule cells proliferation as well as expression of genes involved in calcium-mediated signal transduction. Regulates the circadian expression of several clock genes, including CLOCK, ARNTL/BMAL1, NPAS2 and CRY1. Competes with NR1D1 for binding to their shared DNA response element on some clock genes such as ARNTL/BMAL1, CRY1 and NR1D1 itself, resulting in NR1D1-mediated repression or RORA-mediated activation of clock genes expression, leading to the circadian pattern of clock genes expression. Therefore influences the period length and stability of the clock. Regulates genes involved in lipid metabolism such as apolipoproteins APOA1, APOA5, APOC3 and PPARG. In liver, has specific and redundant functions with RORC as positive or negative modulator of expression of genes encoding phase I and phase II proteins involved in the metabolism of lipids, steroids and xenobiotics, such as CYP7B1 and SULT2A1. Induces a rhythmic expression of some of these genes. In addition, interplays functionally with NR1H2 and NR1H3 for the regulation of genes involved in cholesterol metabolism. Also involved in the regulation of hepatic glucose metabolism through the modulation of G6PC and PCK1. In adipose tissue, plays a role as negative regulator of adipocyte differentiation, probably acting through dual mechanisms. May suppress CEBPB-dependent adipogenesis through direct interaction and PPARG-dependent adipogenesis through competition for DNA-binding. Downstream of IL6 and TGFB and synergistically with RORC isoform 2, is implicated in the lineage specification of uncommitted CD4(+) T-helper (T(H)) cells into T(H)17 cells, antagonizing the T(H)1 program. Probably regulates IL17 and IL17F expression on T(H) by binding to the essential enhancer conserved non-coding sequence 2 (CNS2) in the IL17-IL17F locus. Involved in hypoxia signaling by interacting with and activating the transcriptional activity of HIF1A. May inhibit cell growth in response to cellular stress. May exert an anti-inflammatory role by inducing CHUK expression and inhibiting NF-kappa-B signaling.
- Gene Name:
- RORA
- Uniprot ID:
- P35398
- Molecular Weight:
- 58974.35 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [17139284 ]
- General Function:
- Protein kinase binding
- Specific Function:
- Plays an essential role in the initiation of DNA replication. During the S phase of the cell cycle, the DNA polymerase alpha complex (composed of a catalytic subunit POLA1/p180, a regulatory subunit POLA2/p70 and two primase subunits PRIM1/p49 and PRIM2/p58) is recruited to DNA at the replicative forks via direct interactions with MCM10 and WDHD1. The primase subunit of the polymerase alpha complex initiates DNA synthesis by oligomerising short RNA primers on both leading and lagging strands. These primers are initially extended by the polymerase alpha catalytic subunit and subsequently transferred to polymerase delta and polymerase epsilon for processive synthesis on the lagging and leading strand, respectively. The reason this transfer occurs is because the polymerase alpha has limited processivity and lacks intrinsic 3' exonuclease activity for proofreading error, and therefore is not well suited for replicating long complexes.
- Gene Name:
- POLA1
- Uniprot ID:
- P09884
- Molecular Weight:
- 165911.405 Da
References
- Oshige M, Kuramochi K, Ohta K, Ogawa A, Kuriyama H, Sugawara F, Kobayashi S, Sakaguchi K: Molecular design of cholesterols as inhibitors of DNA polymerase alpha. J Med Chem. 2004 Sep 23;47(20):4971-4. [15369402 ]